International mechanism to confront medical products falsification as a means to improve the quality of Ukrainian pharmacy
Journal Title: Соціальна фармація в охороні здоров’я - Year 2019, Vol 3, Issue 59
Abstract
Aim. To develop recommendations for improving the countering of medical products falsification in Ukraine using the international mechanism to confront, which should lead to increasing the pharmacy. Results. The international mechanism for countering the falsification of medical products, as shown by the analysis of the WHO documents, the MEDIСRIME Convention and others applies to medicines (both for human and veterinary use), as well as medical devices. The use of “falsified” concept in the Ukrainian legislation in relation to medicines and other products includes, in terms of content, substandard, unregistered/unlicensed and falsified products themselves. This concept does not correspond to the international legal definition of such products. The study concluded that the institutional component of the mechanism to counter the falsification of medical products is a system of international organizations, consisting of organizations working in the field of public health, crime control and assistance in carrying out other measures to counter falsification of drugs. Ukraine, as a member of these organizations, can and should use its capabilities in this area. Organizational support, as a necessary component of the mechanism under consideration, consists in the direct activities of these international organizations in such key areas as preventing the falsification of medical products, detecting falsified medical products and responding to such facts. Conclusions. The existing international mechanism for countering the falsification of medical products is a system of informational, institutional and organizational support of states for the prevention, detection and appropriate response. To increase the efficiency of using this mechanism in Ukraine, it is necessary to unify the definition of the concept of falsified medical products with the concepts of substandard, unregistered/unlicensed and falsified medical products, which are accepted by WHO.
Authors and Affiliations
O. S. Soloviov
Keywords
Related Articles
- EP ID EP658203
- DOI 10.24959/uekj.19.24
- Views 185
- Downloads 0
Исследование отдельных компетенций современного руководителя в фармацевтическом секторе отрасли здравоохранения
Цель: исследование отдельных компетенций современного руководителя как координатора организационной системы в фармацевтическом секторе отрасли здравоохранения в рамках адаптивного управления организационной культурой. Ма...
Исследование рынка лекарственных препаратов, применяемых для м естного лечения дерматитов
Целью работы является анализ рынка лекарственных препаратов (ЛП), представленных на фармацевтическом рынке Украины, применяющихся для местной терапии дерматитов, по фармакотерапевтическим группам, составу, формам выпуска...
The substantiation of marketing decisions and approaches to increase the market potential of a hepatotropic drug
Aim. To substantiate and determine the components of marketing decisions in marketing activities in order to increase the market potential of a hepatotropic drug and increase its sales volumes. Materials and methods. Sci...
Анализ проблем рационального использования антибактериальных препаратов в Украине
Цель: проведение анализа текущей ситуации с оборотом антибактериальных препаратов, а так-же разработка эффективных направлений по решению проблемы растущей резистентности бактерий к антибиотикам, в том числе определения...
Analysis of foreign trade activities of the pharmaceutical sector in Ukraine under market conditions
Aim. To study the foreign economic activity of the pharmaceutical sector in Ukraine. Materials and methods. The statistical, analytical, comparative and logical methods, as well as the data of statistics on foreign trade...